Fulcrum Asset Management LLP Purchases 156,704 Shares of Cardinal Health, Inc. $CAH

Posted by Brian Himes on Nov 9th, 2026

Fulcrum Asset Management LLP raised its position in Cardinal Health, Inc. (NYSE:CAH – Free Report) by 223.5% in the third quarter, according to its most recent disclosure with the SEC. The firm owned 226,820 shares of the company’s stock after acquiring an additional 156,704 shares during the period. Cardinal Health makes up about 2.3% of Fulcrum Asset Management LLP’s holdings, making the stock its 3rd largest position. Fulcrum Asset Management LLP’s holdings in Cardinal Health were worth $50,787,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently modified their holdings of the company. BlackRock Inc. acquired a new position in shares of Cardinal Health during the second quarter worth approximately $6,293,115,000. Wellington Management Group LLP grew its position in Cardinal Health by 247.5% in the 2nd quarter. Wellington Management Group LLP now owns 14,860,271 shares of the company’s stock valued at $3,530,206,000 after purchasing an additional 10,584,119 shares during the period. Bank of America Corp DE acquired a new stake in Cardinal Health in the 2nd quarter valued at $689,066,000. Legal & General Group Plc bought a new stake in Cardinal Health during the 2nd quarter valued at $438,870,000. Finally, Pacer Advisors Inc. increased its stake in Cardinal Health by 14.7% during the 1st quarter. Pacer Advisors Inc. now owns 1,565,131 shares of the company’s stock valued at $330,728,000 after purchasing an additional 200,021 shares in the last quarter. Institutional investors own 87.17% of the company’s stock.

Cardinal Health Stock Down 0.3%

Shares of NYSE:CAH opened at $270.99 on Monday. The business’s 50 day moving average is $240.45 and its 200 day moving average is $223.55. Cardinal Health, Inc. has a 12-month low of $180.45 and a 12-month high of $286.29. The stock has a market cap of $62.75 billion, a price-to-earnings ratio of 35.06, a PEG ratio of 1.59 and a beta of 0.53.

Cardinal Health (NYSE:CAH – Get Free Report) last released its quarterly earnings results on Thursday, November 5th. The company reported $3.26 EPS for the quarter, beating analysts’ consensus estimates of $2.94 by $0.32. The business had revenue of $67.51 billion during the quarter, compared to analyst estimates of $66.67 billion. Cardinal Health had a negative return on equity of 102.72% and a net margin of 0.71%. Cardinal Health’s quarterly revenue was up 5.5% compared to the same quarter last year. During the same period in the prior year, the firm posted $2.55 EPS. As a group, equities research analysts expect that Cardinal Health, Inc. will post 12.86 earnings per share for the current year.

Wall Street Analyst Weigh In

CAH has been the topic of several research reports. Citigroup upped their price objective on shares of Cardinal Health from $265.00 to $280.00 and gave the stock a “buy” rating in a report on Wednesday, August 12th. Weiss Ratings upgraded shares of Cardinal Health from a “buy (b)” rating to a “buy (b+)” rating in a report on Thursday, October 8th. TD Cowen boosted their target price on shares of Cardinal Health from $275.00 to $280.00 and gave the stock a “buy” rating in a research report on Thursday, August 13th. JPMorgan Chase & Co. upped their target price on shares of Cardinal Health from $215.00 to $260.00 and gave the stock a “neutral” rating in a report on Thursday, August 13th. Finally, Barclays upped their target price on shares of Cardinal Health from $258.00 to $275.00 and gave the stock an “overweight” rating in a report on Thursday, August 13th. Sixteen analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $272.50.

Get Our Latest Stock Analysis on CAH

Insider Activity

In related news, insider Jessica L. Mayer sold 29,436 shares of the firm’s stock in a transaction dated Tuesday, August 18th. The shares were sold at an average price of $236.19, for a total transaction of $6,952,488.84. Following the transaction, the insider directly owned 33,076 shares of the company’s stock, valued at $7,812,220.44. This trade represents a 47.09% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Stephen M. Mason sold 35,000 shares of the firm’s stock in a transaction dated Tuesday, August 18th. The shares were sold at an average price of $236.40, for a total transaction of $8,274,000.00. Following the transaction, the chief executive officer directly owned 18,061 shares in the company, valued at $4,269,620.40. The trade was a 65.96% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders sold 210,271 shares of company stock worth $49,626,657. Company insiders own 0.12% of the company’s stock.

Cardinal Health News Summary

Here are the key news stories impacting Cardinal Health this week:

Positive Sentiment: Fiscal Q1 adjusted EPS was $3.26, ahead of analyst expectations, while revenue rose 5% year over year to $67.5 billion and also topped estimates. The company raised its FY2027 adjusted EPS guidance to $12.80–$13.00, above the FactSet estimate of $12.57. Cardinal Health reports first-quarter results and raises outlook
Positive Sentiment: Management cited specialty growth, strong demand for generics and customer renewals as supports for the raised outlook. Cardinal Health also completed a $500 million share repurchase program during the quarter. Q1 earnings call highlights
Positive Sentiment: Royal Bank of Canada raised its price target to $295 from $276 and reiterated an “outperform” rating, signaling continued analyst optimism. Royal Bank of Canada recommendations
Negative Sentiment: Medical distribution faced pressure, including modest commodity and petroleum-related headwinds. The company’s results and raised forecast indicate these pressures were outweighed by strength in pharmaceuticals and specialty. Cardinal Health sees healthy demand despite commodity pressure

Cardinal Health Profile

(Free Report)

Cardinal Health is a healthcare services and products company that distributes pharmaceuticals and medical supplies. Its customers include pharmacies, hospitals, surgery centers, physician offices and other healthcare providers.

The company’s businesses include pharmaceutical distribution and specialty services, as well as the sourcing and distribution of medical and surgical products. Its offerings support areas such as specialty medications, medication management and supply-chain operations.

Cardinal Health traces its roots to a wholesale business founded in Ohio in 1971 and later expanded into pharmaceutical distribution.